CoChat

Interventions for treating anxiety after stroke

Open access
Campbell Burton, C. Alexia, Holmes, John, Murray, Jenni, Gillespie, David, Lightbody, C. Elizabeth, Watkins, Caroline L, Knapp, Peter · 2011 · Cochrane Database of Systematic Reviews
Cited by 63

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Approximately 20% of stroke patients experience anxiety at some point after stroke. OBJECTIVES: To determine if any treatment for anxiety after stroke decreases the proportion of patients with anxiety disorders or symptoms, and to determine the effect of treatment on quality of life, disability, depression, social participation, risk of death or caregiver burden. SEARCH METHODS: We searched the trials register of the Cochrane Stroke Group (October 2010), CENTRAL (The Cochrane Library 2010, Issue 4), MEDLINE (1950 to October 2010), EMBASE (1947 to October 2010), PsycINFO (1806 to October 2010), Allied and Complementary Medicine database (AMED) (1985 to October 2010), Cumulative Index to Nursing and Allied Health (CINAHL) (1982 to October 2010), Proquest Digital Dissertations (1861 to October 2010), and Psychological Database for Brain Impairment Treatment Efficacy (PsycBITE) (2004 to October 2010). In an effort to identify further published, unpublished and ongoing trials, we searched trial registries and major international stroke conference proceedings, scanned reference lists, and contacted select individuals known to the review team who are actively involved in psychological aspects of stroke research, and the Association of the British Pharmaceutical Industry. SELECTION CRITERIA: Two review authors independently screened and selected titles and abstracts for inclusion in the review. Randomised trials of any intervention in patients with stroke where the treatment of anxiety was an outcome were eligible. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data for analysis. We performed a narrative review. A meta-analysis was planned but not carried out as studies were not of sufficient quality to warrant doing so. MAIN RESULTS: We included two trials (three interventions) involving 175 participants with co-morbid anxiety and depression in the review. Both trials used the Hamilton Anxiety Scale (HAM-A) to assess anxiety, and neither included a placebo control group. One trial randomised 81 patients to paroxetine, paroxetine plus psychotherapy or standard care. Mean level of anxiety severity scores were 58% and 71% lower in the paroxetine, and paroxetine plus psychotherapy groups respectively compared with those in standard care at follow-up (P < 0.01). The second trial randomised 94 stroke patients, also with co-morbid anxiety and depression, to receive buspirone hydrochloride or standard care. At follow-up, the mean level of anxiety was significantly lower for those receiving buspirone relative to controls (P < 0.01). Half of the participants receiving paroxetine experienced adverse events that included nausea, vomiting or dizziness; however, only 14% of those receiving buspirone experienced nausea or palpitations. No information was provided about the duration of symptoms associated with adverse events. AUTHORS' CONCLUSIONS: There is insufficient evidence to guide the treatment of anxiety after stroke. The data available suggest that pharmaceutical therapy (paroxetine and buspirone) may be effective in reducing anxiety symptoms in stroke patients with co-morbid anxiety and depression. No information was available for stroke patients with anxiety only. Randomised placebo controlled trials are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd008860.pub2

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 45

  1. Wang, 2005, A clinical trial of paroxetine and psychotherapy in patients with poststroke depression and anxiety, Chinese Mental Health Journal, 19, 564
  2. Zhang, 2005, Effects of buspirone hydrochloride on post-stroke affective disorder and neural function, Chinese Journal of Clinical Rehabilitation, 9, 8
  3. Kimura, 2003, Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression, American Journal of Geriatric Psychiatry, 11, 320, 10.1097/00019442-200305000-00009 · DOI
  4. Li, 2005, Effect of early functional training on psychological rehabilitation in stroke patients, Chinese Journal of Clinical Rehabilitation, 9, 176
  5. Liu, 2004, Recent effect of drug intervention on post-stroke anxiety, Chinese Journal of Clinical Rehabilitation, 8, 6600
  6. Morrison, 1998, Improving emotional outcomes following acute stroke: a preliminary evaluation of a work-book based intervention, Scottish Medical Journal, 43, 52, 10.1177/003693309804300208 · DOI
  7. Rorsman, 2006, Can electroacupuncture or transcutaneous nerve stimulation influence cognitive and emotional outcome after stroke?, Journal of Rehabilitation Medicine, 38, 13, 10.1080/16501970510040362 · DOI
  8. Wu, 2008, Clinical observation on post-stroke anxiety neurosis treated by acupuncture, Journal of Traditional Chinese Medicine, 28, 186, 10.1016/S0254-6272(08)60043-6 · DOI
  9. Ye, 2006, Effect of paxil and berhomine on poststroke anxiety-depression and neurological recovery, Chinese Journal of Clinical Rehabilitation, 10, 153
  10. Ahlsiö, 1984, Disablement and quality of life after stroke, Stroke, 15, 886, 10.1161/01.STR.15.5.886 · DOI · Paper page
  11. 1980, Diagnostic and Statistical Manual for Mental Disorders (DSM-III)
  12. 1987, Diagnostic and Statiscal Manual of Mental Disorders (DSM-III-R)
  13. 1994, Diagnostic and Statisical Manual of Mental Disorders
  14. 2000, Diagnostic and Statistical Manual of Mental Disorders
  15. Baldwin, 2005, Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology, Journal of Psychopharmacology, 19, 567, 10.1177/0269881105059253 · DOI · Paper page
  16. Beck, 1961, An inventory for measuring depression, Archives of General Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
  17. Beck, 1979, Cognitive Therapy of Depression
  18. Beck, 1997, The past and future of cognitive therapy, Journal of Psychotherapy Practice, 6, 276
  19. Burvill, 1995, Anxiety disorders after stroke: results from the Perth Community Stroke Study, British Journal of Psychiatry, 166, 328, 10.1192/bjp.166.3.328 · DOI · Paper page
  20. Craig, 2003, Modern pharmacology with clinical applications
  21. DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  22. Gelder, 2006, Shorter Oxford Textbook of Psychiatry
  23. Givens, 2006, Older patients' aversion to antidepressants. A qualitative study, Journal of General Internal Medicine, 21, 146
  24. Hackett, 2010, Pharmaceutical interventions for emotionalism after stroke, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003690.pub3 · DOI · Paper page
  25. Hamilton, 1959, The assessment of anxiety states by rating, British Journal of Medical Psychology, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  26. Hamilton, 1960, Rating scale for depression, Journal of Neurology, Neurosurgery and Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  27. Hatano, 1976, Experience from a multicentre stroke register: a preliminary report, Bulletin of the World Health Organization, 54, 541
  28. House, 1991, Mood disorders in the year after first stroke, British Journal of Psychiatry, 158, 83, 10.1192/bjp.158.1.83 · DOI · Paper page
  29. Hyde, 2005, A qualitative study exploring how GPs decide to prescribe antidepressants, British Journal of General Practice, 55, 755
  30. Jorm, 2004, Effectiveness of complementary and self-help treatments for anxiety disorders, Medical Journal of Australia, 181 Suppl, S29
  31. Langhorne, 2000, Medical complications after stroke - multicenter study, Stroke, 31, 1223, 10.1161/01.STR.31.6.1223 · DOI · Paper page
  32. Lepine, 2002, The epidemiology of anxiety disorders: prevalence and societal costs, Journal of Clinical Psychiatry, 63 Suppl 14, 4
  33. Lincoln, 1998, Rehabilitation needs of community stroke patients, Disability and Rehabilitation, 20, 457, 10.3109/09638289809166110 · DOI · Paper page
  34. Mahoney, 1965, Functional evaluation: the Barthel Index, Maryland State Medical Journal, 14, 61
  35. Max, 2002, Psychiatric disorders after childhood stroke, Journal of the American Academiy of Child and Adolescent Psychiatry, 41, 555, 10.1097/00004583-200205000-00013 · DOI
  36. Montgomery, 1979, A new depression scale designed to be sensitive to change, British Journal of Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
  37. 2005, Post-traumatic stress disorder. The management of PTSD in adult and children in primary and secondary care
  38. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011
  39. Sharpe, 1990, Mood disorders in long-term survivors of stroke: associations with brain lesion location and volume, Psychological Medicine, 20, 815, 10.1017/S0033291700036503 · DOI · Paper page
  40. Shimoda, 1998, Effect of anxiety disorder on impairment and recovery from stroke, Journal of Neuropsychiatry and Clinical Neurosciences, 10, 34, 10.1176/jnp.10.1.34 · DOI · Paper page
  41. Boeijen, 2005, Efficacy of self help manuals for anxiety disorders in primary care: a systematic review, Family Practice, 22, 192, 10.1093/fampra/cmh708 · DOI · Paper page
  42. Rijswijk, 2009, Barriers in recognising, diagnosing and managing depressive and anxiety disorders as experienced by Family Physicians; a focus group study, BMC Family Practice, 10, 1
  43. Wade, 1985, Social activities after stroke: measurement and natural history using the Frenchay Activities Index, International Rehabilitation Medicine, 7, 176, 10.3109/03790798509165991 · DOI · Paper page
  44. Ware, 1993, SF-36 Health Survey: Manual and Interpretation Guide
  45. Campbell Burton, 2010, Interventions for treating anxiety after stroke (Protocol), Cochrane Database of Systematic Reviews, 10.1002/14651858.CD008860 · DOI

Cited by

Metadata

Authors
Campbell Burton, C. A., Holmes, J., Murray, J., Gillespie, D., Lightbody, C. E., Watkins, C. L., & Knapp, P.
Venue
Cochrane Database of Systematic Reviews
Published
2011-12-07
Issue
12
Pages
CD008860-CD008860
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4235912322
Cited by
63
References
8
Type
reference entry
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.